193 related articles for article (PubMed ID: 29794239)
21. Utility of Dynamic Susceptibility Contrast Perfusion-Weighted MR Imaging and
Qiao Z; Zhao X; Wang K; Zhang Y; Fan D; Yu T; Shen H; Chen Q; Ai L
AJNR Am J Neuroradiol; 2019 Feb; 40(2):253-259. PubMed ID: 30655259
[TBL] [Abstract][Full Text] [Related]
22. Identification of single-dose, dual-echo based CBV threshold for fractional tumor burden mapping in recurrent glioblastoma.
Anil A; Stokes AM; Chao R; Hu LS; Alhilali L; Karis JP; Bell LC; Quarles CC
Front Oncol; 2023; 13():1046629. PubMed ID: 36733305
[TBL] [Abstract][Full Text] [Related]
23. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
[TBL] [Abstract][Full Text] [Related]
24. Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method.
Cebeci H; Aydin O; Ozturk-Isik E; Gumus C; Inecikli F; Bekar A; Kocaeli H; Hakyemez B
Eur J Radiol; 2014 Oct; 83(10):1914-9. PubMed ID: 25087109
[TBL] [Abstract][Full Text] [Related]
25. Consistency of normalized cerebral blood volume values in glioblastoma using different leakage correction algorithms on dynamic susceptibility contrast magnetic resonance imaging data without and with preload.
Hedderich D; Kluge A; Pyka T; Zimmer C; Kirschke JS; Wiestler B; Preibisch C
J Neuroradiol; 2019 Feb; 46(1):44-51. PubMed ID: 29753641
[TBL] [Abstract][Full Text] [Related]
26. Glioma grading by dynamic susceptibility contrast perfusion and
Brendle C; Hempel JM; Schittenhelm J; Skardelly M; Reischl G; Bender B; Ernemann U; la Fougère C; Klose U
Neuroradiology; 2018 Apr; 60(4):381-389. PubMed ID: 29464269
[TBL] [Abstract][Full Text] [Related]
27. Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomas.
Ellingson BM; Zaw T; Cloughesy TF; Naeini KM; Lalezari S; Mong S; Lai A; Nghiemphu PL; Pope WB
J Magn Reson Imaging; 2012 Jun; 35(6):1472-7. PubMed ID: 22281731
[TBL] [Abstract][Full Text] [Related]
28. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
[TBL] [Abstract][Full Text] [Related]
29. Regional and voxel-wise comparisons of blood flow measurements between dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI) and arterial spin labeling (ASL) in brain tumors.
White CM; Pope WB; Zaw T; Qiao J; Naeini KM; Lai A; Nghiemphu PL; Wang JJ; Cloughesy TF; Ellingson BM
J Neuroimaging; 2014; 24(1):23-30. PubMed ID: 22672084
[TBL] [Abstract][Full Text] [Related]
30. Validation of a T1 and T2* leakage correction method based on multiecho dynamic susceptibility contrast MRI using MION as a reference standard.
Stokes AM; Semmineh N; Quarles CC
Magn Reson Med; 2016 Aug; 76(2):613-25. PubMed ID: 26362714
[TBL] [Abstract][Full Text] [Related]
31. Comparison of BOLD cerebrovascular reactivity mapping and DSC MR perfusion imaging for prediction of neurovascular uncoupling potential in brain tumors.
Pillai JJ; Zacà D
Technol Cancer Res Treat; 2012 Aug; 11(4):361-74. PubMed ID: 22376130
[TBL] [Abstract][Full Text] [Related]
32. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
[TBL] [Abstract][Full Text] [Related]
33. Quantitative Cerebral Blood Volume Image Synthesis from Standard MRI Using Image-to-Image Translation for Brain Tumors.
Wang B; Pan Y; Xu S; Zhang Y; Ming Y; Chen L; Liu X; Wang C; Liu Y; Xia Y
Radiology; 2023 Aug; 308(2):e222471. PubMed ID: 37581504
[TBL] [Abstract][Full Text] [Related]
34. Reliable estimation of microvascular flow patterns in patients with disrupted blood-brain barrier using dynamic susceptibility contrast MRI.
Hansen MB; Tietze A; Kalpathy-Cramer J; Gerstner ER; Batchelor TT; Østergaard L; Mouridsen K
J Magn Reson Imaging; 2017 Aug; 46(2):537-549. PubMed ID: 27902858
[TBL] [Abstract][Full Text] [Related]
35. Effects of Susceptibility Artifacts on Perfusion MRI in Patients with Primary Brain Tumor: A Comparison of Arterial Spin-Labeling versus DSC.
Maral H; Ertekin E; Tunçyürek Ö; Özsunar Y
AJNR Am J Neuroradiol; 2020 Feb; 41(2):255-261. PubMed ID: 31974077
[TBL] [Abstract][Full Text] [Related]
36. Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas.
Young R; Babb J; Law M; Pollack E; Johnson G
J Magn Reson Imaging; 2007 Oct; 26(4):1053-63. PubMed ID: 17896374
[TBL] [Abstract][Full Text] [Related]
37. Paradoxical perfusion metrics of high-grade gliomas with an oligodendroglioma component: quantitative analysis of dynamic susceptibility contrast perfusion MR imaging.
Sunwoo L; Choi SH; Yoo RE; Kang KM; Yun TJ; Kim TM; Lee SH; Park CK; Kim JH; Park SW; Sohn CH; Won JK; Park SH; Kim IH
Neuroradiology; 2015 Nov; 57(11):1111-20. PubMed ID: 26232204
[TBL] [Abstract][Full Text] [Related]
38. Synthesizing a Contrast-Enhancement Map in Patients with High-Grade Gliomas Based on a Postcontrast MR Imaging Quantification Only.
Warntjes M; Blystad I; Tisell A; Larsson EM
AJNR Am J Neuroradiol; 2018 Dec; 39(12):2194-2199. PubMed ID: 30409854
[TBL] [Abstract][Full Text] [Related]
39. Posttreatment DSC-MRI is Predictive of Early Treatment Failure in Children with Supratentorial High-Grade Glioma Treated with Erlotinib.
Lucas JT; Knapp BJ; Uh J; Hua CH; Merchant TE; Hwang SN; Patay Z; Broniscer A
Clin Neuroradiol; 2018 Sep; 28(3):393-400. PubMed ID: 28382379
[TBL] [Abstract][Full Text] [Related]
40. Evaluating Multisite rCBV Consistency from DSC-MRI Imaging Protocols and Postprocessing Software Across the NCI Quantitative Imaging Network Sites Using a Digital Reference Object (DRO).
Bell LC; Semmineh N; An H; Eldeniz C; Wahl R; Schmainda KM; Prah MA; Erickson BJ; Korfiatis P; Wu C; Sorace AG; Yankeelov TE; Rutledge N; Chenevert TL; Malyarenko D; Liu Y; Brenner A; Hu LS; Zhou Y; Boxerman JL; Yen YF; Kalpathy-Cramer J; Beers AL; Muzi M; Madhuranthakam AJ; Pinho M; Johnson B; Quarles CC
Tomography; 2019 Mar; 5(1):110-117. PubMed ID: 30854448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
